Midazolam HCl

Product NDC: 52533-001
11-digit product format: 525330001
Labeler code: 52533
Product ID: 52533-001_fec562f9-7b6e-43d9-9a90-d3cf3f9f9e80
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Midazolam HCl
Dosage form: INJECTION, SOLUTION
Route: INTRAVENOUS
Labeler: Cantrell Drug Company
Marketing category: UNAPPROVED DRUG OTHER
Marketing start: 2012-04-13
Marketing end: 0000-00-00
Substance: MIDAZOLAM HYDROCHLORIDE
Active strength: 1 mg/mL
Pharmacologic classes: Benzodiazepine [EPC],Benzodiazepines [CS]
DEA schedule: CIV
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 22 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	52533-001		I	Inactivated by FDA	2026-10-12
excluded product	product	52533-001		I	Inactivated by FDA	2026-10-12
excluded product	product	52533-001		I	Inactivated by FDA	2026-10-12
excluded product	product	52533-001		D	Discontinued by firm	2026-10-12
excluded product	product	52533-001		I	Inactivated by FDA	2026-10-12
excluded product	product	52533-001		I	Inactivated by FDA	2026-10-12
excluded product	product	52533-001		I	Inactivated by FDA	2026-10-12
excluded product	product	52533-001		I	Inactivated by FDA	2026-10-12
excluded product	product	52533-001		D	Discontinued by firm	2026-10-12
excluded product	product	52533-001		I	Inactivated by FDA	2026-10-12
excluded product	product	52533-001		I	Inactivated by FDA	2026-10-12
excluded package	package	52533-001	52533-001-16	I	Inactivated by FDA	2026-10-12
excluded package	package	52533-001	52533-001-72	I	Inactivated by FDA	2026-10-12
excluded package	package	52533-001	52533-001-05	I	Inactivated by FDA	2026-10-12
excluded package	package	52533-001	52533-001-02	D	Discontinued by firm	2026-10-12
excluded package	package	52533-001	52533-001-01	I	Inactivated by FDA	2026-10-12
excluded package	package	52533-001	52533-001-60	I	Inactivated by FDA	2026-10-12
excluded package	package	52533-001	52533-001-75	I	Inactivated by FDA	2026-10-12
excluded package	package	52533-001	52533-001-31	I	Inactivated by FDA	2026-10-12
excluded package	package	52533-001	52533-001-15	D	Discontinued by firm	2026-10-12
excluded package	package	52533-001	52533-001-77	I	Inactivated by FDA	2026-10-12
excluded package	package	52533-001	52533-001-71	I	Inactivated by FDA	2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 8 · 444 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52533-001-72	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52533-001-75	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52533-001-01	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52533-001-60	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52533-001-31	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52533-001-05	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52533-001-02	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52533-001-71	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52533-001-15	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52533-001-77	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52533-001-16	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52533-001-72	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52533-001-75	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52533-001-01	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52533-001-60	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52533-001-31	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52533-001-05	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52533-001-02	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52533-001-71	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52533-001-15	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52533-001-77	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52533-001-16	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	52533-001-72	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	52533-001-75	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	52533-001-01	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	52533-001-60	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	52533-001-31	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
1d526338-43ba-4cef-8730-5a757122f8ce	Product name	1	20260218
8118475d-d61b-4326-b353-56e9cf8c8d9f	Product name	3	20260218
f69f3735-bf62-03e6-cc7a-5af4af89ec8a	Product name	5	20250516
362d7abb-94e6-4c60-9a58-266894157713	Product name	1	20231023
4cc03496-da49-494d-b71d-757fe6737fa2	Product name	1	20230717
06641162-4d53-492d-8ff2-5951a469060f	Product name	1	20230420
46ca420c-e4d5-4e6c-9b2f-cea269a262e8	Product name	1	20230320
6bd95106-a412-1dad-b9cc-4cb74bfb27ce	Product name	2	20230315
f1e0dc7e-7d61-4625-b6d9-4894927679d7	Product name	2	20211025
e4870509-7e28-6f92-f0be-dd3dd889a9cf	Product name	5	20200810
b84efe2b-3f4e-4b09-90f9-1d24a61ec30e	Product name	1	20190808
6e9d4a47-c464-b93e-aebc-ad7bffc9c4cd	Product name	2	20190619
444b3e50-f226-46ef-bfca-2e7035d140cd	Product name	1	20190611
816b97af-edc5-4060-aff1-b814bdbcad50	Product name	1	20190415
bb7f99f4-8b2b-42a4-8f5a-fcf7dc204f16	Product name	1	20181220
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
419aab54-5d5a-4146-9453-026d4a9991be	Product name	2	20170525
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831
290f523a-f9db-9774-b5a9-e1f908ac1782	Product name	1	20150828
89dac932-b90a-4410-9ab1-84c53e57de25	Product name	1	20150316
31f18c4e-1938-700a-43de-b9e218c36edc	Product name	1	20140508
5668b646-cd56-c3c7-bdea-3f6b1a8840db	Product name	1	20140508
684ea482-2e8b-14af-5664-b98f1e402036	Product name	1	20140508
810ab97e-f109-f41c-7c83-6a652a9cbf43	Product name	1	20140508
87711080-88eb-65c5-b2dd-bf99e700a372	Product name	1	20140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2dd	Product name	1	20140508
b060cc1a-fe47-856b-0b77-4448b5963de8	Product name	1	20140508
c6b65c52-69c7-df49-550a-a50c137f6218	Product name	1	20140508
ec2149b3-5c6d-5344-f757-c86411073075	Product name	1	20140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Indexing SPL table
NDC	Effective	Indexing SPL	Related label
52533-001-05	2020-01-31	9d75b9cf-f2d2-f424-e053-dadaa90a57ce	Midazolam HCl 1 mg/mL in 0.9% Sodium Chloride 30 mL PCA Vial
52533-001-31	2020-01-31	9d75b9d0-b16a-f424-e053-dadaa90a57ce	Midazolam HCl 1 mg/mL in 0.9% Sodium Chloride 50 mL Bag
52533-001-75	2020-01-31	9d75b9cf-d5d4-f424-e053-dadaa90a57ce	Midazolam HCl 1 mg/mL in 0.9% Sodium Chloride 100 mL Bag
52533-001-77	2020-01-31	9d75b9d0-4b9d-f424-e053-dadaa90a57ce	Midazolam HCl 1 mg/mL in 0.9% Sodium Chloride 50 mL Bag
52533-001-01	2019-11-27	9855d018-dcd3-cd31-e053-dbdaa90ab51a	Midazolam HCl 1 mg/mL in 0.9% Sodium Chloride 100 mL Bag
52533-001-16	2019-11-27	9855e2a2-4002-60a7-e053-dbdaa90a05bd	Midazolam HCl 1 mg/mL in 0.9% Sodium Chloride 2 mL Syringe
52533-001-60	2019-11-27	9855e2a2-3f63-60a7-e053-dbdaa90a05bd	Midazolam HCl 1 mg/mL in 0.9% Sodium Chloride 3 mL Syringe
52533-001-71	2019-11-27	9855d018-e43e-cd31-e053-dbdaa90ab51a	Midazolam HCl 1 mg/mL in 0.9% Sodium Chloride 100 mL Bag
52533-001-72	2019-11-27	9855d018-d9b5-cd31-e053-dbdaa90ab51a	Midazolam HCl 1 mg/mL in 0.9% Sodium Chloride 125 mL Bag

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
52533-001-16	Midazolam HCl	2 mL in 1 SYRINGE, PLASTIC	INJECTION, SOLUTION	2	7
52533-001-05	Midazolam HCl	30 mL in 1 VIAL, PATENT DELIVERY SYSTEM	INJECTION, SOLUTION	30	5
52533-001-01	Midazolam HCl	100 mL in 1 BAG	INJECTION, SOLUTION	100	3
52533-001-31	Midazolam HCl	50 mL in 1 BAG	INJECTION, SOLUTION	50	3
52533-001-71	Midazolam HCl	100 mL in 1 BAG	INJECTION, SOLUTION	100	3
52533-001-77	Midazolam HCl	50 mL in 1 BAG	INJECTION, SOLUTION	50	3
52533-001-60	Midazolam HCl	3 mL in 1 SYRINGE, PLASTIC	INJECTION, SOLUTION	3	2
52533-001-75	Midazolam HCl	100 mL in 1 BAG	INJECTION, SOLUTION	100	2
52533-001-72	Midazolam HCl	125 mL in 1 BAG	INJECTION, SOLUTION	125	1

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
52533-001-01	ML - Milliliter	52533-001	fcefcebc-3468-412e-bcec-4f8d8d5ac52b	1	2015-10-02
52533-001-16	ML - Milliliter	52533-001	00dfd7a1-bdd4-40c0-97ba-aac8591c1245	1	2015-10-02
52533-001-71	ML - Milliliter	52533-001	9b4a32e5-7c40-48ce-b421-ce5d0f791d58	1	2015-10-02
52533-001-72	ML - Milliliter	52533-001	1bcd4eba-ec30-4746-98de-6215848fe195	1	2015-10-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
MIDAZOLAM HYDROCHLORIDE	ACTIVE INGREDIENT	W7TTW573JJ	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	7
MIDAZOLAM	ACTIVE MOIETY	R60L0SM5BC	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	7
EDETATE DISODIUM	INACTIVE INGREDIENT	7FLD91C86K	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	7
Sodium Chloride	INACTIVE INGREDIENT	451W47IQ8X	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	7
WATER	INACTIVE INGREDIENT	059QF0KO0R	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	7
MIDAZOLAM HYDROCHLORIDE	ACTIVE INGREDIENT	W7TTW573JJ	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	4
MIDAZOLAM	ACTIVE MOIETY	R60L0SM5BC	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	4
EDETATE DISODIUM	INACTIVE INGREDIENT	7FLD91C86K	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	4
SODIUM CHLORIDE	INACTIVE INGREDIENT	451W47IQ8X	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	4
WATER	INACTIVE INGREDIENT	059QF0KO0R	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	4
MIDAZOLAM HYDROCHLORIDE	ACTIVE INGREDIENT	W7TTW573JJ	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	3
MIDAZOLAM HYDROCHLORIDE	ACTIVE INGREDIENT	W7TTW573JJ	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	3
MIDAZOLAM HYDROCHLORIDE	ACTIVE INGREDIENT	W7TTW573JJ	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	3
MIDAZOLAM	ACTIVE MOIETY	R60L0SM5BC	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	3
Midazolam	ACTIVE MOIETY	R60L0SM5BC	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	3
MIDAZOLAM	ACTIVE MOIETY	R60L0SM5BC	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	3
EDETATE DISODIUM	INACTIVE INGREDIENT	7FLD91C86K	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	3
SODIUM CHLORIDE	INACTIVE INGREDIENT	451W47IQ8X	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	3
Sodium Chloride	INACTIVE INGREDIENT	451W47IQ8X	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	3
SODIUM CHLORIDE	INACTIVE INGREDIENT	451W47IQ8X	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	3
WATER	INACTIVE INGREDIENT	059QF0KO0R	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	3
WATER	INACTIVE INGREDIENT	059QF0KO0R	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	3
WATER	INACTIVE INGREDIENT	059QF0KO0R	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	3
MIDAZOLAM HYDROCHLORIDE	ACTIVE INGREDIENT	W7TTW573JJ	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	2
MIDAZOLAM HYDROCHLORIDE	ACTIVE INGREDIENT	W7TTW573JJ	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	2
MIDAZOLAM HYDROCHLORIDE	ACTIVE INGREDIENT	W7TTW573JJ	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	2
MIDAZOLAM	ACTIVE MOIETY	R60L0SM5BC	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	2
MIDAZOLAM	ACTIVE MOIETY	R60L0SM5BC	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	2
MIDAZOLAM	ACTIVE MOIETY	R60L0SM5BC	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	2
EDETATE DISODIUM	INACTIVE INGREDIENT	7FLD91C86K	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	2
EDETATE DISODIUM	INACTIVE INGREDIENT	7FLD91C86K	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	2
EDETATE DISODIUM	INACTIVE INGREDIENT	7FLD91C86K	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	2
Sodium Chloride	INACTIVE INGREDIENT	451W47IQ8X	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	2
SODIUM CHLORIDE	INACTIVE INGREDIENT	451W47IQ8X	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	2
SODIUM CHLORIDE	INACTIVE INGREDIENT	451W47IQ8X	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	2
WATER	INACTIVE INGREDIENT	059QF0KO0R	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	2
WATER	INACTIVE INGREDIENT	059QF0KO0R	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	2
WATER	INACTIVE INGREDIENT	059QF0KO0R	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	2
MIDAZOLAM HYDROCHLORIDE	ACTIVE INGREDIENT	W7TTW573JJ	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	1
Midazolam	ACTIVE MOIETY	R60L0SM5BC	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	1
Sodium Chloride	INACTIVE INGREDIENT	451W47IQ8X	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
52533-001	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	7	Legacy NDC, 1 package rows	20140502_d9cd30df-4888-4041-8416-b59ecd89a063.zip
52533-001	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	5	Legacy NDC, 1 package rows	20160206_62796814-f815-480c-90e8-179f674525ad.zip
52533-001	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	3	Legacy NDC, 1 package rows	20130408_7d589a64-b58d-48ee-84f6-fe326055e878.zip
52533-001	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	3	Legacy NDC, 1 package rows	20121119_eededbc2-b9a3-461f-98e6-1c86a3c06745.zip
52533-001	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	3	Legacy NDC, 1 package rows	20150113_47129d45-ac90-4933-a541-3515d7b3c37a.zip
52533-001	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	3	Legacy NDC, 1 package rows	20160406_68a028fe-0057-41de-a8ae-1e3f847f2cc6.zip
52533-001	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	2	Legacy NDC, 1 package rows	20140502_deaf74d7-e0ee-4950-8086-f94b720fb109.zip
52533-001	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	2	Legacy NDC, 1 package rows	20150113_79c8a669-8dd2-44a5-8703-7994bad1600e.zip
52533-001	MIDAZOLAM HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]	1	Legacy NDC, 1 package rows	20121119_0c39086b-787b-4400-a79b-8e3316a7ab50.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
W7TTW573JJ	MIDAZOLAM HYDROCHLORIDE	59467-96-8	MIDAZOLAM HYDROCHLORIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
311700	midazolam 1 MG/ML Injectable Solution	PSN	d9cd30df-4888-4041-8416-b59ecd89a063	7
311700	midazolam 1 MG/ML Injectable Solution	SCD	d9cd30df-4888-4041-8416-b59ecd89a063	7
311700	midazolam (as midazolam hydrochloride) 1 MG/ML Injectable Solution	SY	d9cd30df-4888-4041-8416-b59ecd89a063	7
311700	midazolam 1 MG/ML Injectable Solution	PSN	62796814-f815-480c-90e8-179f674525ad	5
311700	midazolam 1 MG/ML Injectable Solution	SCD	62796814-f815-480c-90e8-179f674525ad	5
311700	midazolam (as midazolam hydrochloride) 1 MG/ML Injectable Solution	SY	62796814-f815-480c-90e8-179f674525ad	5
311700	midazolam 1 MG/ML Injectable Solution	PSN	eededbc2-b9a3-461f-98e6-1c86a3c06745	3
311700	midazolam 1 MG/ML Injectable Solution	PSN	47129d45-ac90-4933-a541-3515d7b3c37a	3
311700	midazolam 1 MG/ML Injectable Solution	PSN	68a028fe-0057-41de-a8ae-1e3f847f2cc6	3
311700	midazolam 1 MG/ML Injectable Solution	PSN	7d589a64-b58d-48ee-84f6-fe326055e878	3
311700	midazolam 1 MG/ML Injectable Solution	SCD	eededbc2-b9a3-461f-98e6-1c86a3c06745	3
311700	midazolam 1 MG/ML Injectable Solution	SCD	7d589a64-b58d-48ee-84f6-fe326055e878	3
311700	midazolam 1 MG/ML Injectable Solution	SCD	68a028fe-0057-41de-a8ae-1e3f847f2cc6	3
311700	midazolam 1 MG/ML Injectable Solution	SCD	47129d45-ac90-4933-a541-3515d7b3c37a	3
311700	midazolam (as midazolam hydrochloride) 1 MG/ML Injectable Solution	SY	eededbc2-b9a3-461f-98e6-1c86a3c06745	3
311700	midazolam (as midazolam hydrochloride) 1 MG/ML Injectable Solution	SY	7d589a64-b58d-48ee-84f6-fe326055e878	3
311700	midazolam (as midazolam hydrochloride) 1 MG/ML Injectable Solution	SY	68a028fe-0057-41de-a8ae-1e3f847f2cc6	3
311700	midazolam (as midazolam hydrochloride) 1 MG/ML Injectable Solution	SY	47129d45-ac90-4933-a541-3515d7b3c37a	3
311700	midazolam 1 MG/ML Injectable Solution	PSN	79c8a669-8dd2-44a5-8703-7994bad1600e	2
311700	midazolam 1 MG/ML Injectable Solution	PSN	deaf74d7-e0ee-4950-8086-f94b720fb109	2
311700	midazolam 1 MG/ML Injectable Solution	SCD	79c8a669-8dd2-44a5-8703-7994bad1600e	2
311700	midazolam 1 MG/ML Injectable Solution	SCD	deaf74d7-e0ee-4950-8086-f94b720fb109	2
311700	midazolam (as midazolam hydrochloride) 1 MG/ML Injectable Solution	SY	79c8a669-8dd2-44a5-8703-7994bad1600e	2
311700	midazolam (as midazolam hydrochloride) 1 MG/ML Injectable Solution	SY	deaf74d7-e0ee-4950-8086-f94b720fb109	2
311700	midazolam 1 MG/ML Injectable Solution	PSN	0c39086b-787b-4400-a79b-8e3316a7ab50	1
311700	midazolam 1 MG/ML Injectable Solution	SCD	0c39086b-787b-4400-a79b-8e3316a7ab50	1
311700	midazolam (as midazolam hydrochloride) 1 MG/ML Injectable Solution	SY	0c39086b-787b-4400-a79b-8e3316a7ab50	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
52533-001-01	52533000101	100 mL in 1 BAG	100 ml	Historical
52533-001-05	52533000105	30 mL in 1 VIAL, PATENT DELIVERY SYSTEM	30 ml	Historical
52533-001-16	52533000116	2 mL in 1 SYRINGE, PLASTIC	2 ml	Historical
52533-001-31	52533000131	50 mL in 1 BAG	50 ml	Historical
52533-001-60	52533000160	3 mL in 1 SYRINGE, PLASTIC	3 ml	Historical
52533-001-71	52533000171	100 mL in 1 BAG	100 ml	Historical
52533-001-72	52533000172	125 mL in 1 BAG	125 ml	Historical
52533-001-75	52533000175	100 mL in 1 BAG	100 ml	Historical
52533-001-77	52533000177	50 mL in 1 BAG	50 ml	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Midazolam HCl 1 mg/mL in 0.9% Sodium Chloride 50 mL Bag	Cantrell Drug Company	2016-04-06	HUMAN PRESCRIPTION DRUG LABEL	3
Midazolam HCl 1 mg/mL in 0.9% Sodium Chloride 30 mL PCA Vial	Cantrell Drug Company	2016-01-14	HUMAN PRESCRIPTION DRUG LABEL	5
Midazolam HCl 1 mg/mL in 0.9% Sodium Chloride 50 mL Bag	Cantrell Drug Company	2015-01-12	HUMAN PRESCRIPTION DRUG LABEL	3
Midazolam HCl 1 mg/mL in 0.9% Sodium Chloride 100 mL Bag	Cantrell Drug Company	2015-01-12	HUMAN PRESCRIPTION DRUG LABEL	2
Midazolam HCl 1 mg/mL in 0.9% Sodium Chloride 2 mL Syringe	Cantrell Drug Company	2014-05-02	HUMAN PRESCRIPTION DRUG LABEL	7
Midazolam HCl 1 mg/mL in 0.9% Sodium Chloride 3 mL Syringe	Cantrell Drug Company	2014-05-02	HUMAN PRESCRIPTION DRUG LABEL	2
Midazolam HCl 1 mg/mL in 0.9% Sodium Chloride 100 mL Bag	Cantrell Drug Company	2013-03-21	HUMAN PRESCRIPTION DRUG LABEL	3
Midazolam HCl 1 mg/mL in 0.9% Sodium Chloride 100 mL Bag	Cantrell Drug Company	2012-11-18	HUMAN PRESCRIPTION DRUG LABEL	3
Midazolam HCl 1 mg/mL in 0.9% Sodium Chloride 125 mL Bag	Cantrell Drug Company	2012-04-13	HUMAN PRESCRIPTION DRUG LABEL	1